Musk Touts ‘Biological Enhancement’ as Neuralink Pursues Human Bandwidth Breakthrough

Musk's framing recasts brain-computer interfaces from a medical device story into a general-purpose communications thesis: the constraint is human output speed, not machine capability. That matters because it widens the perceived addressable market beyond patients toward anyone whose work involves interfacing with machines, which is a different regulatory and ethical conversation than the one Neuralink's clinical work has prompted. Whether bandwidth claims translate into demonstrated, safe human performance remains the open question, and it is the milestone worth tracking.